| Timothy Joseph Steinagle, DO | |
|
300 Stonecrest Blvd Ste 300, Smyrna, TN 37167-6801 | |
| (615) 267-6600 | |
| Not Available |
| Full Name | Timothy Joseph Steinagle |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 34 Years |
| Location | 300 Stonecrest Blvd Ste 300, Smyrna, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649263708 | NPI | - | NPPES |
| 3307498 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 1248 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Stonecrest Medical Center | Smyrna, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Orthopaedic Alliance Pa | 5193625069 | 308 |
News Archive
Genetic analysis of human patients has shown that mutations in genes involved in synaptic communication can drive neuropsychiatric and neurological diseases such as autism spectrum disorder and Alzheimer's disease.
SilverTree Health, the premier provider of physician billing and practice management resources, is pleased to announce a new marketing agreement between Desert Physicians Association (DPA) and its affiliate, Integra Physicians Network (IPN). This new partnership leverages the strengths of both organizations: SilverTree's high-tech nature and profitability and DPA's membership base.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
APR announces today the launch of its new Corporate Website reflecting a clear strategic change in the APR Business Model and competitive positioning in order to better compete in the very rapidly changing Healthcare market. The company repositioning is also reflected in its revised logo.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
› Verified 9 days ago
| Entity Name | Tennessee Orthopaedic Alliance Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538153937 PECOS PAC ID: 5193625069 Enrollment ID: O20040109000069 |
News Archive
Genetic analysis of human patients has shown that mutations in genes involved in synaptic communication can drive neuropsychiatric and neurological diseases such as autism spectrum disorder and Alzheimer's disease.
SilverTree Health, the premier provider of physician billing and practice management resources, is pleased to announce a new marketing agreement between Desert Physicians Association (DPA) and its affiliate, Integra Physicians Network (IPN). This new partnership leverages the strengths of both organizations: SilverTree's high-tech nature and profitability and DPA's membership base.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
APR announces today the launch of its new Corporate Website reflecting a clear strategic change in the APR Business Model and competitive positioning in order to better compete in the very rapidly changing Healthcare market. The company repositioning is also reflected in its revised logo.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
› Verified 9 days ago
| Entity Name | Select Health Of Sc, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962904946 PECOS PAC ID: 7416212972 Enrollment ID: O20210623003548 |
News Archive
Genetic analysis of human patients has shown that mutations in genes involved in synaptic communication can drive neuropsychiatric and neurological diseases such as autism spectrum disorder and Alzheimer's disease.
SilverTree Health, the premier provider of physician billing and practice management resources, is pleased to announce a new marketing agreement between Desert Physicians Association (DPA) and its affiliate, Integra Physicians Network (IPN). This new partnership leverages the strengths of both organizations: SilverTree's high-tech nature and profitability and DPA's membership base.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
APR announces today the launch of its new Corporate Website reflecting a clear strategic change in the APR Business Model and competitive positioning in order to better compete in the very rapidly changing Healthcare market. The company repositioning is also reflected in its revised logo.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Joseph Steinagle, DO Po Box 306556, Nashville, TN 37230-6556 Ph: (865) 243-8153 | Timothy Joseph Steinagle, DO 300 Stonecrest Blvd Ste 300, Smyrna, TN 37167-6801 Ph: (615) 267-6600 |
News Archive
Genetic analysis of human patients has shown that mutations in genes involved in synaptic communication can drive neuropsychiatric and neurological diseases such as autism spectrum disorder and Alzheimer's disease.
SilverTree Health, the premier provider of physician billing and practice management resources, is pleased to announce a new marketing agreement between Desert Physicians Association (DPA) and its affiliate, Integra Physicians Network (IPN). This new partnership leverages the strengths of both organizations: SilverTree's high-tech nature and profitability and DPA's membership base.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
APR announces today the launch of its new Corporate Website reflecting a clear strategic change in the APR Business Model and competitive positioning in order to better compete in the very rapidly changing Healthcare market. The company repositioning is also reflected in its revised logo.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
› Verified 9 days ago
Dr. William C Mayfield Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Stonecrest Blvd Ste 200, Smyrna, TN 37167 Phone: 615-355-0533 Fax: 615-355-0957 | |
James M Fish, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Stonecrest Blvd Ste 230, Smyrna, TN 37167 Phone: 615-730-8626 Fax: 615-840-6169 | |
Juris Shibayama, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Stonecrest Blvd Ste 300, Smyrna, TN 37167 Phone: 615-267-6600 Fax: 615-267-6603 |